PicoCELA (PCLA) Stock Price, News & Analysis

Company Overview

PicoCELA, Inc. is a clinical-stage biotechnology company focused on the development of next-generation vaccines and immunotherapies based on its proprietary self-assembling protein nanoparticle platform. The company engineers functionalized, virus-like protein particles designed to present disease-relevant antigens in their native conformation, with the goal of eliciting potent B-cell and T-cell responses. PicoCELA’s platform enables the rapid design and production of vaccine candidates against infectious diseases as well as antigen-specific immunotherapies for certain cancers.

The company’s pipeline includes vaccine programs targeting SARS-CoV-2 and other respiratory pathogens, leveraging its nanoparticle scaffolds to display full-length viral spike proteins or other key antigens. Preclinical studies have demonstrated robust neutralizing antibody titers and T-cell activation in animal models, supporting progression toward clinical trials. Beyond infectious disease, PicoCELA is exploring oncology applications in which tumor-associated antigens are presented on its nanoscaffold to stimulate a targeted immune attack against cancer cells.

Founded in 2019 and headquartered in Connecticut, PicoCELA went public via a Nasdaq listing in 2021. The company collaborates with academic research centers and contract development organizations across the United States to advance its preclinical and future clinical-stage programs. PicoCELA’s leadership team comprises experienced executives and scientific founders with backgrounds in immunology, protein engineering and vaccine development, positioning the company to address unmet medical needs through its modular nanoparticle technology.

Key Stats

• Today's Range: $6.60 to $7.31
• 50-Day Range: $3.07 to $9.11
• 52-Week Range: $1.35 to $19.61
• Volume: 60,190 shs
• Average Volume: 368,531 shs
• Market Capitalization: $285.60 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

PicoCELA Stock Analysis - MarketRank™

PicoCELA scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

PicoCELA has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

PicoCELA has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

PicoCELA has a P/B Ratio of 0.09. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

1,074.59% of the float of PicoCELA has been sold short.

Short Interest Ratio / Days to Cover

PicoCELA has a short interest ratio ("days to cover") of 2.94, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in PicoCELA has recently increased by 113.02%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PicoCELA does not currently pay a dividend.

Dividend Growth

PicoCELA does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.14

News Sentiment

PicoCELA has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Technology companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for PicoCELA this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for PCLA on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

1 people have added PicoCELA to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, PicoCELA insiders have not sold or bought any company stock.

Percentage Held by Institutions

PicoCELA has minimal institutional ownership at this time.

Company Calendar

• Today: 8/17/2026
• Fiscal Year End: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Technology
• Industry: Communications Equipment
• Sub-Industry: Communications Equipment
• Current Symbol: NASDAQ:PCLA
• CIK: 2018462
• Web: picocela.com
• Phone: 81 03-6661-2780
• Fax: N/A
• Employees: 53
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $3.64 million
• Price / Sales: 0.08
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $82.71 per share
• Price / Book: 0.09

Miscellaneous

• Outstanding Shares: 40,000
• Free Float: N/A
• Market Cap: $285.60 thousand
• Optionable: N/A
• Beta: 11.15